The Wharton Moneyball Post Game Podcast


Wharton Moneyball: MLB Predictions, NFL Storylines, & Hudl Analytics

Ep. 163

Show from 8/14/19

In this episode of Wharton Moneyball our hosts talk with the Chief Product Officer and Co-Founder of Hudl on how data and analytics has changed the way players are recruited across the country as well as how the company is using its technology to help coaches during games. Have you ever wondered what company is in the forefront of tracking analytics from sports athletes all over the country? Next hosts Cade Massey and Adi Wyner talk with Cornell professor Steven Strogatz on his latest book before discussing the latest in the playoff races across major league baseball and the analytical storylines they are both following across College and NFL football.


Steven Strogatz is an applied mathematician who works in the areas of nonlinear dynamics and complex systems, often on topics inspired by the curiosities of everyday life. He loves finding math in places where you’d least expect it—and then using it to illuminate life’s mysteries, big and small. Steven is also a Jacob Gould Schurman Professor of Applied Mathematics at Cornell University

Follow him on Twitter @StevenStrogatz

Check out his book:

John Wirtz is the Chief Product Officer and Co-Founder of Hudl. The mobile video software provides tools for coaches and athletes to review game footage and improve team play. Hudl has changed the way players are recruited to play college sports across the country. Also the software facilitates the sharing of highlight reels with sports fans and recruitment scouts.

Follow him on Twitter @Jmwirtz

Visit Hudl:

More Episodes


7/22/2020: COVID-19, Sports, David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.